Figure 4. Components of cardiovascular safety assessment in the study of anticancer drugs and suggested interventions to improve early identification of clinically significant cardiotoxicity.

AE indicates adverse events; CV, cardiovascular; CVD, cardiovascular disease; EF, ejection fraction; EMR, electronic medical record; hERG, human ether‐a‐go‐go–related gene; hiPSC‐CM, human induced pluripotent stem cell–derived cardiomyocytes; and GLS, global longitudinal strain.